PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Obeticholic acid - Biliary cirrhosis
PAD Profile : Obeticholic acid - Biliary cirrhosis
Keywords :
Primary biliary cholangitis, PBC
Brand Names Include :
Ocaliva
Traffic Light Status
Status 1 of 1.
Status :
Red
Important
Formulations :
- Tablets
Important Information :
Dose adjustment and monitoring required in pre-existing moderate / severe hepatic impairment.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2017
Not Set
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
Associated BNF Codes
01. Gastro-Intestinal System
01.09.01. Drugs affecting biliary composition and flow